Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Weight Loss 1Quality of Life 1Parasomnias 1Neoplasms 1Melanoma 1Depression 1Cachexia 1Breast Cancer - Female 1Anxiety Disorders 1

Interventions

Surveys and Questionnaires 5Ketamine 3Standard of Care 2Methods 2Early Intervention, Educational 2Yoga 1Ultraviolet Therapy 1Self-Help Groups 1Psychotherapy, Group 1Psychotherapy 1Psychiatric Rehabilitation 1Propranolol 1Practice Guidelines as Topic 1N-Methyl-3,4-methylenedioxyamphetamine 1Mindfulness-Based Stress Reduction 1Midazolam 1Melatonin 1Meditation 1Interviews as Topic 1Exercise Therapy 1Educational Status 1Cognitive Behavioral Therapy 1Caregivers 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Anxiety Disorders × Melatonin × Clear all
NCT01355523 2014-05-06

MELODY

Herlev Hospital

Phase 2/3 Terminated
54 enrolled 27 charts
Breast

Anxiety Disorders, Breast Neoplasms, Depression, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡